FASgen Diagnostic Tests Identify Ovarian Cancer Progression And Apoptosis
FASgen Diagnostics, LLC is pleased to report that results of studies using the Company’s FAS-detect(TM) IHC and FAS- detect(TM) ELISA research tests were the subject of an address to Society of Gynecologic Oncologists annual meeting last week in Tampa, Florida.
More: continued here
Filed under: Women's Health / OBGYN on April 3rd, 2008